IMRT 2018

Rathod et al., Oral Oncol, 2013

Tata Memorial Randomized Trial

Caveat:

At a median followup of 40 months (inter-quartile range 26-50 months):

The 3-year estimates of loco-regional control with 95% confidence intervals (95%CI) were 88.2% (75.4–100%) for 3D-CRT 80.5% (66.1–94.9%) for IMRT (p = 0.45).